溫諾平注射液10公絲/公撮

Country: Թայվան

language: չինարեն

source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

PIL PIL (PIL)
05-09-2023
PAR PAR (PAR)
12-04-2020

active_ingredient:

VINORELBINE TARTRATE

MAH:

友華生技醫藥股份有限公司 臺北市北投區承德路6段128號13樓 (12397982)

ATC_code:

L01CA04

pharmaceutical_form:

注射劑

composition:

VINORELBINE TARTRATE (1002000610) MG

units_in_package:

小瓶

class:

製 劑

prescription_type:

限由醫師使用

manufactured_by:

PIERRE FABRE MEDICAMENT LES CAUQUILLOUS, 81500 LAVAUR, FRANCE FR

therapeutic_area:

vinorelbine

therapeutic_indication:

非小細胞肺癌,移轉性乳癌

leaflet_short:

有效日期: 2028/06/29; 英文品名: NAVELBINE 10MG/ML INJECTABLE SOLUTION

authorization_date:

1998-06-29

PIL

                                _Désignation:_
NAVELBINE 10-50 MG 10 FL - TW
_Code :_
335514
_Format à plat :_
630 X 105 MM
_Format plié :_
35 X 105 MM
_Impression R°:_
NOIR + MAGENTA
_Impression V°:_
NOIR + MAGENTA
_Papier:_
50 G
_Edition :_
2
FAREVA PAU
NAVELBINE 335514.indd 1
NAVELBINE 335514.indd 1
30/01/2023 10:39:46
30/01/2023 10:39:46
NAVELBINE 335514.indd 2
NAVELBINE 335514.indd 2
30/01/2023 10:39:47
30/01/2023 10:39:47
                                
                                read_full_document